# New clinical data on lecanemab to be presented at CTAD conference 2026

- Source: PR Newswire M&A
- Published: 2026-10-30T07:17:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/new-clinical-data-on-lecanemab-to-be-presented-at-ctad-conference-2026-302924703.html
- Canonical: https://groundlevelnews.com/story/new-clinical-data-on-lecanemab-to-be-presented-at-ctad-conference-2026-04c3f6/

STOCKHOLM, October 30, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present new clinical and real-world evidence on lecanemab (Leqembi®) at the Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston, November 16-19, 2026. The...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._